Geode Capital Management, LLC Vaxart, Inc. Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,660,119 shares of VXRT stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,660,119

Previous 2,601,139 2.27%

Holding current value

$1.22 Million

Previous $1.72 Million 36.48%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$0.41 - $0.94 $24,181 - $55,441	58,980 Added 2.27%	2,660,119 $1.09 Million
Q4 2024 Feb 12, 2025	BUY	$0.54 - $0.86 $31,271 - $49,803	57,911 Added 2.28%	2,601,139 $1.72 Million
Q3 2024 Nov 12, 2024	BUY	$0.58 - $0.99 $201,100 - $343,257	346,725 Added 15.79%	2,543,228 $2.16 Million
Q2 2024 Aug 09, 2024	BUY	$0.53 - $1.3 $833 - $2,044	1,573 Added 0.07%	2,196,503 $1.47 Million
Q1 2024 May 13, 2024	BUY	$0.56 - $1.41 $130,422 - $328,384	232,897 Added 11.87%	2,194,930 $2.85 Million
Q4 2023 Feb 13, 2024	BUY	$0.57 - $0.85 $99,976 - $149,088	175,398 Added 9.82%	1,962,033 $1.12 Million
Q3 2023 Nov 13, 2023	BUY	$0.69 - $0.85 $150,230 - $185,067	217,726 Added 13.88%	1,786,635 $1.34 Million
Q2 2023 Aug 11, 2023	SELL	$0.6 - $1.41 $656,138 - $1.54 Million	-1,093,564 Reduced 41.07%	1,568,909 $1.15 Million
Q1 2023 May 15, 2023	BUY	$0.71 - $1.25 $58,893 - $103,686	82,949 Added 3.22%	2,662,473 $2.02 Million
Q4 2022 Feb 13, 2023	BUY	$0.75 - $2.24 $236,946 - $707,678	315,928 Added 13.96%	2,579,524 $2.48 Million
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $79,629 - $171,450	38,100 Added 1.71%	2,263,596 $4.93 Million
Q2 2022 Aug 12, 2022	SELL	$2.7 - $5.28 $22,191 - $43,396	-8,219 Reduced 0.37%	2,225,496 $7.79 Million
Q1 2022 May 13, 2022	BUY	$4.29 - $6.64 $602,062 - $931,864	140,341 Added 6.7%	2,233,715 $11.3 Million
Q4 2021 Feb 11, 2022	SELL	$5.77 - $7.96 $108,862 - $150,181	-18,867 Reduced 0.89%	2,093,374 $13.1 Million
Q3 2021 Nov 12, 2021	BUY	$6.67 - $9.8 $555,197 - $815,732	83,238 Added 4.1%	2,112,241 $16.8 Million
Q2 2021 Aug 13, 2021	BUY	$5.06 - $10.78 $2.99 Million - $6.37 Million	590,704 Added 41.07%	2,029,003 $15.2 Million
Q1 2021 May 12, 2021	BUY	$5.64 - $23.33 $1.14 Million - $4.73 Million	202,575 Added 16.39%	1,438,299 $8.7 Million
Q4 2020 Feb 12, 2021	BUY	$3.5 - $7.98 $238,633 - $544,084	68,181 Added 5.84%	1,235,724 $7.06 Million
Q3 2020 Nov 13, 2020	BUY	$4.78 - $16.97 $2.47 Million - $8.76 Million	516,141 Added 79.24%	1,167,543 $7.76 Million
Q2 2020 Aug 13, 2020	BUY	$1.68 - $8.85 $525,772 - $2.77 Million	312,960 Added 92.47%	651,402 $5.76 Million
Q1 2020 May 14, 2020	BUY	$0.34 - $2.87 $99,862 - $842,956	293,713 Added 656.65%	338,442 $599,000
Q2 2019 Aug 14, 2019	BUY	$0.63 - $2.04 $14,675 - $47,519	23,294 Added 108.67%	44,729 $29,000
Q2 2018 Aug 14, 2018	BUY	$2.88 - $6.0 $17,928 - $37,350	6,225 Added 40.93%	21,435 $64,000
Q1 2018 May 15, 2018	BUY	$4.95 - $9.02 $75,289 - $137,194	15,210 New	15,210 $77,000

Others Institutions Holding VXRT

# of Institutions

102

Shares Held

28M

Call Options Held

14.3K

Put Options Held

55.2K

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $58.2M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Vaxart, Inc. Transaction History